Back
Design Therapeutics Stock Price Chart
"EarnPhone": The Investment Hidden in Plain Sight
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
DSGN
Design Therapeutics
Last Price:
5.88
Seasonality Move:
-19.8%
7 Day Trial
ALL ACCESS PASS
$
7
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight selling pressure.
Design Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.66 | Buy |
| 20-day SMA: | 5.2 | Buy |
| 50-day SMA: | 4.82 | Buy |
| 200-day SMA: | 3.62 | Buy |
| 8-day EMA: | 5.64 | Buy |
| 20-day EMA: | 5.3 | Buy |
| 50-day EMA: | 4.85 | Buy |
| 200-day EMA: | 4.23 | Buy |
Design Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 63.14 | Buy |
| Chaikin Money Flow: | -157563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.7 - 5.58) | Buy |
| Bollinger Bands (100): | (3.68 - 5.02) | Buy |
Design Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics Stock
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.88 while DSGN 8-day simple moving average is 5.66, which is a Buy signal.
- The stock price of DSGN is 5.88 while Design Therapeutics 20-day SMA is 5.20, which makes it a Buy.
- Design Therapeutics 50-day simple moving average is 4.82 while DSGN share price is 5.88, making it a Buy technically.
- DSGN stock price is 5.88 and Design Therapeutics 200-day simple moving average is 3.62, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Sell
47
Design Therapeutics (DSGN)
is a Sell
Is Design Therapeutics a Buy or a Sell?
-
Design Therapeutics stock is rated a Sell
The current Design Therapeutics [DSGN] share price is $5.88. The Score for DSGN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Design Therapeutics Stock Info
Market Cap:
332.93M
Price in USD:
5.88
Share Volume:
405.16K
Design Therapeutics 52-Week Range
52-Week High:
6.91
52-Week Low:
1.96
Sell
47
Design Therapeutics (DSGN)
is a Sell
Design Therapeutics Share Price Forecast
-
What is the Design Therapeutics stock price today?
The Design Therapeutics stock price is 5.88 USD today. -
Will DSGN stock go up or go down?
Design Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Design Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics is overvalued.
Is Design Therapeutics Stock a Buy?
- Design Therapeutics share price is 5.88 while DSGN 8-day exponential moving average is 5.64, which is a Buy signal.
- The stock price of DSGN is 5.88 while Design Therapeutics 20-day EMA is 5.30, which makes it a Buy.
- Design Therapeutics 50-day exponential moving average is 4.85 while DSGN share price is 5.88, making it a Buy technically.
- DSGN stock price is 5.88 and Design Therapeutics 200-day simple moving average is 4.23, creating a Buy signal.
Fundamental Analysis of Design Therapeutics
Is Design Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.39 per share, and a decrease next year of $0.26 per share.
Technical Analysis of Design Therapeutics
Should I short Design Therapeutics stock?
- DSGN Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Design Therapeutics is a Buy
- Design Therapeutics Relative Strength Index (RSI) is 63.14, which suggest Design Therapeutics is overbought
- The Bollinger Bands (25) for Design Therapeutics is (4.7 - 5.58), which suggest Design Therapeutics is a Buy
- The Bollinger Bands (100) for Design Therapeutics is (3.68 - 5.02), which suggest Design Therapeutics is a Buy
* Design Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.